Details

Autor(en) / Beteiligte

• Nikishina, Irina P
• Arsenyeva, Svetlana V
• Matkava, Valeria G
• Arefieva, Alia N
• Kaleda, Mariya I
• Smirnov, Alexandr V
• Blank, Leonid M
• Kostik, Mikhail M

Titel

Successful experience of tofacitinib treatment in patients with Fibrodysplasia Ossificans Progressiva

Ist Teil von

• Pediatric rheumatology online journal, 2023-08, Vol.21 (1), p.92-92, Article 92

Ort / Verlag

London: BioMed Central Ltd

Erscheinungsjahr

2023

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• Fibrodysplasia ossificans progressive (FOP) is an ultra-rare genetic disorder that is caused by a mutation in the ACVR1 gene and provokes severe heterotopic ossification. Since flares of the disease are associated with inflammation, it is assumed that JAK inhibitors can control active FOP due to blocking multiple signaling pathways. Keywords: Fibrodysplasia ossificans progressiva, FOP, Heterotopic ossification, Tofacitinib, Autoinflammation, Spondyloarthritis-like disease, ACVR1 gene, Bone morphogenetic protein, BMP